Dihydroalterperylenol from endophytic fungus Alternaria semiverrucosa and its antitumour activity uncovered by transcriptome analysis, molecular docking and molecular dynamics simulations

通过转录组分析、分子对接和分子动力学模拟揭示了内生真菌半疣链格孢菌中的二氢交链孢酚及其抗肿瘤活性

阅读:3
作者:Mingfei Yang,Yongzhong Lu,Long Han,Zhangjiang He,Jichuan Kang

Abstract

Medicinal plants host a variety of endophytic fungi, which produce numerous secondary metabolites with diverse biological activities. The present study identified ten natural compounds isolated from the endophytic fungal strain Alternaria semiverrucosa, derived from Taxus wallichiana var. mairei. The cytotoxicity of all isolated compounds was evaluated against six tumor cell lines. Dihydroalterperylenol (compound 1) exhibited the highest cytotoxicity against HeLa cells (IC50=6.43±3.0 µM). Cells were treated with 0.1% DMSO and 6.0 µmol/l for 24 h, after which total RNA was extracted for transcriptome library construction and sequencing analysis. Transcriptome analysis identified 140 differentially expressed genes (DEGs), including 99 upregulated and 41 downregulated genes. Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed significant enrichment of these DEGs in the TGFβ signaling pathway and Hippo signaling pathway. Gene ontology analysis indicated that the DEGs were predominantly involved in the regulation of cell proliferation. Notably, reverse transcription‑quantitative PCR validation confirmed the upregulation of three genes (TGIF2, ID1 and BMP2) which was consistent with the transcriptome sequencing results. Additionally, molecular docking and molecular dynamics simulations were employed to explore the molecular mechanisms underlying the antitumor activity of compound 1. The results suggest that compound 1 exerts its anticancer effects in cervical cancer by regulating the expression of genes TGIF2, ID1 and BMP2.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。